The COVID-19 high-stage-specific markers (i.e., FOS, CXCL8, HLAA, JAK3, ICAM1, and H2BC4) were overexpressed in higher-stage samples, that is, increased expression levels of the markers were observed in asymptomatic to critical samples. This evidence concerns the gene H2BC4 and COVID-19.